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BASIC AND EXPERIMENTAL RESEARCH
Reduced Ischemia-Reoxygenation Injury in Rat
Intestine After Luminal Preservation With a Tailored
Solution
Anne Margot Roskott,1,5 Vincent B. Nieuwenhuijs,1 Henri G. D. Leuvenink,1 Gerard Dijkstra,2
Petra Ottens,1 Marina H. de Jager,3 Patricia Gonalves Dias Pereira,3 Vaclav Fidler,4
Geny M. M. Groothuis,3 Rutger J. Ploeg,1 and Inge A. M. de Graaf3
Background. The intestine is extremely sensitive to ischemic preservation and reoxygenation injury. Current vascular
perfusion and cold storage with University of Wisconsin (UW) solution neglect the intestinal lumen and the ongoing
mucosal metabolism during hypothermia. This study was designed to test the effects of luminal preservation with an
alternative preservation solution in addition to the common vascular flush with UW solution on graft viability after
preservation and ex vivo reoxygenation.
Methods. Rat intestine was preserved on ice for 6 hr in UW solution orWilliamsMedium E with additional buffering,
impermeants, and a colloid (WMEplus) after being stapled or after flushing and filling the lumen with the respective
preservation solution. Tissue slices were prepared from fresh and preserved intestines and were incubated with oxygen
for 6 hr at 37°C to assess the viability after reoxygenation.
Results. Directly after preservation, histologic damage was mild and unaffected by preservation strategy. Contrary to
luminal preservation, closed preservation resulted in significantly decreased ATP levels compared with control. Reoxy-
genation aggravated damage and revealed differences between the strategies. Luminal preservation better maintained
the ATP levels and histologic integrity (vs. closed preservation) for both solutions. Histomorphologic integrity was
superior after preservation with WMEplus (vs. UW solution). Expression of stress responsive genes was least up-
regulated in the slices from tissue preserved luminally with WMEplus.
Conclusions. In conclusion, preservation and reoxygenation injury can be attenuated by luminal preservation with
WMEplus.
Keywords: Intestinal transplantation, Ischemia-reoxygenation injury, Preservation solutions, Preservation techniques.
(Transplantation 2010;90: 622–629)
Intestinal transplantation (ITx) was introduced in the 1990sas a promising permanent therapeutic option for patients
with irreversible intestinal failure. During the past 20 years,
the modifications in patient selection, surgical technique,
postoperative management, and evolution in immunosup-
pressive protocols have significantly improved the results of
ITx (1, 2). Nevertheless, ITx continues to be a challenging
transplant procedure because long-term outcome remains
inferior compared with other organ transplants. Brain death in
the donor, preservation injury, surgical manipulation dur-
ing retrieval and transplantation, and ischemia-reperfusion
injury (IRI) compromise the mucosal barrier (3–8). This
consequently leads to the induction of immunoinflammatory
processes and bacterial translocation, which predispose the
recipient to sepsis and rejection as the main causes of mor-
bidity and mortality after ITx (1–2, 8). Maintenance of intes-
tinal integrity is, therefore, critical to enhance the viability of
the intestinal graft and reduce posttransplant complications.
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The intestinal mucosa is well perfused under physio-
logic conditions and extremely vulnerable to ischemia (9).
Unfortunately, an ischemic period after retrieval during pres-
ervation is inevitable to bridge the gap between donor and
recipient. The current standard for intestinal preservation is a
vascular washout with University of Wisconsin (UW) solu-
tion followed by cold, static storage (CS) in UW solution.
Although the gold standard for many years, it has become
clear that UW solution is not optimal for the preservation of
the intestinal graft (10–13). Also, vascular preservation alone
without exposure of the mucosa to the preservation solution
may be insufficient to maintain intestinal integrity during
clinically relevant storage periods (14, 15). Recent studies
suggest that the intestine benefits from luminal contact with
substrates in the preservation solution that meet physiologic
demands (11, 16–22). However, no consensus has been
reached about the optimal solution composition and strategy
for intestinal preservation.
Preservation damage is known to be aggravated by nor-
mothermic reperfusion and reoxygenation. Unfortunately,
all elements of injury to the intestine will accumulate upon
reperfusion during transplantation. For this reason, a trans-
plantmodel complicates the distinction of responsible factors
of damage. To better unravel the possibly deleterious effect
of preservation and reoxygenation as such, we have used
precision-cut intestinal tissue slices that enabled us to specif-
ically study the early events of reoxygenation injury. In the
past, we have successfully used reoxygenated precision-cut
liver slices as an ex vivomodel for reoxygenation of preserved
liver (23). Intestinal slices contain all cell types in their natural
configuration and remain functionally active in culture for at
least 8 to 24 hr (24).
The aim of this study was to test the effect of luminal
preservation with amodified enriched intestinal preservation
solution after a common vascular washout with UW solution
on the maintenance of intestinal graft viability. Intestinal in-
tegrity was evaluated directly after preservation and after
reoxygenation of intestinal slices.
RESULTS
Viability of Preserved Intestinal Tissue
Nonpreserved intestine (T0) showed hardly any struc-
turaldamage, reflectedbyameanParkScoreof0.13(range0–1).
Preservation clearly affected the morphology: the mean Park
Score after preservationwas significantly higher (P0.001) than
for nonpreserved control tissue, regardless of preservation solu-
tion and strategy (Table 1). No differences in Park Score were
observed between the different preservation groups.
ATP levels were decreased after preservation (P0.04)
in tissue of both closed preservation groups compared with
control tissue, whereas no significant decrease was observed
in the luminally preserved group (Table 1). However, there
were no significant differences in ATP levels between the dif-
ferent preservation strategy groups when directly compared
with each other.
Viability of Reoxygenated Intestinal Slices
Morphological integrity of reoxygenated slices from
preserved intestinal tissue was significantly decreased (re-
flected by the higher total morphology score) in comparison
with reoxygenated slices from control tissue (Fig. 1A) for all
four preservation groups. However, morphology was signifi-
cantly less affected in slices from tissue preserved withWME-
plus than in slices from tissue preserved with UW solution,
independent of the preservation strategy (P0.001, Fig. 1A,
Table 2). Also, independent of the preservation solution,
morphology was superior after luminal preservation than
after closed preservation (P0.001, Fig. 1A, Table 2). The
beneficial effect of luminal preservation and WMEplus was
reflected by all separate morphology parameters (Table 2)
except for villus flattening, which was not prevented by either
combination of strategy and preservation solution. Further-
more, viability of the muscle layer and the shape of epithelial
cells were not significantly improved by luminal preservation.
The ATP content was significantly lower in reoxygen-
ated slices from all preservation groups than in reoxygenated
slices of tissue that was not preserved (Fig. 1B). After direct
comparison of the preservation groups, it was noted that in-
dependent of the used preservation solution, ATP content
was higher in slices after luminal preservation than after
closed preservation (Table 2).
Gene Expression in Reoxygenated Slices
Remarkably, less RNA could be extracted from reoxygen-
ated slices that were preserved with UW solution without lumi-
nal exposure than from slices from preserved tissue from the
other groups (Table 2). The highest RNA recoverywas obtained
from slices of tissue that was luminally preserved with WME-
plus. RNA yield reflects the capacity of cells to produce RNA.
RNAyieldclosely corresponded to theoutcomeofotherviability
parameters (histology and ATP content), which indicates that
more RNA could be extracted from qualitatively better tissue.
In general, gene expression was least affected (most
resembled expression in slices from control tissue) when lu-
minal preservation with WMEplus was applied (Table 3).
Furthermore, Table 3 shows the contribution of the preser-
vation solution and preservation strategy to the differences in
gene expression. The expression of villin, a protein that is
exclusively expressed in the epithelial cells, was unaffected by
luminal preservation with WMEplus but significantly down-





Control, not preserved (T0) 0.13 (0–1.0) 1.96 (0.7–2.7)
UW closed (T6) 2.6a (0–5.0) 1.4b (0.4–3.2)
UW luminal (T6) 2.4a (0.5–4.0) 2.1 (1.3–5.3)
WMEplus closed (T6) 2.6a (1.0–3.8) 1.29b (0.6–2.5)
WME plus luminal (T6) 2.2a (2.0–3.0) 1.31 (0.7–2.6)
Values represent the mean of intestinal tissue of eight rats with range in
parenthesis.
There were no significant differences in Park Score or ATP levels between
the preservation strategy groups when directly compared with each other.
a Values are significantly higher than control (P0.001).
b Values are significantly lower than control (P0.05).
T0, control, no preservation, direct assessment; T6, 6 hr preservation,
followed by assessment; UW, University of Wisconsin; WMEplus, Williams
Medium E with additional buffering, impermeants, and a colloid.
© 2010 Lippincott Williams & Wilkins 623Roskott et al.
regulated in the other preservation groups. However, direct
comparison of the preservation solutions and preservation
strategies only showed a beneficial effect of the luminal pres-
ervation strategy.
The expression of genes known for their response to
cellular stress, inducible nitric oxide synthase (iNOS), inter-
leukin (IL)-6, heme oxygenase (HO)-1, and heat shock pro-
tein 70 (Hsp70) was most pronouncedly up-regulated in
slices preserved according to the clinical standard (closed
preservation with UW solution). This induction was signifi-
cantly lower after preservation with WMEplus, and in the
case of iNOS and HO-1, this induction was also significant
after luminal preservation. Furthermore, the mRNA expres-
sion of tight junction proteins was up-regulated in slices from
preserved tissue comparedwith control. Again, expressionmost
closely resembled that of slices from control tissue whenWME-
plus in combination with luminal preservation was applied.
DISCUSSION
Ischemic preservation and reoxygenation on reperfu-
sion negatively affect the intestinal graft and result in inflam-
matory and immunological complications after ITx. Stan-
dard hypothermic preservation causes substantial damage to
the vulnerable intestinal graft, particularly because vascular
washout andCSwithUWsolution seem to insufficiently pro-
tect this organ (20). Development of a specific intestinal pres-
ervation solution and protective conditions is essential to
improve the long-term outcome of ITx. We assessed the po-
tential of luminal preservation and the use of an alternative
CS solution to protect intestinal graft quality.
This study endorses that actual graft damage is not re-
vealed directly after a clinically relevant preservation span of 6
hr, irrespective of the preservation solution and strategy, but
FIGURE 1. Viability of intestinal slices after reoxygenation. (A) Morphology score: scores of separate morphologic
parameters were added up to a total morphology score (maximum score 18) to indicate overall viability of the slices. (a)
Values are significantly higher than control value (P0.05). (b) Values are significantly lower than for slices from tissue
preserved with University of Wisconsin (UW) solution, independent of the preservation strategy (P0.001). (c) Values are
significantly lower than for slices of tissue after closedpreservation, independent of the preservation solution (P0.001). (B)
ATP level: values represent mean ATP level (nmol/mg protein) of tissue of eight experiments (intestines of eight rats). (a)
ATP levels are significantly lower than control (P0.05). (b) ATP levels were significantly higher than after closed preser-
vation, independent of the preservation solution (P0.001). The band in the middle of the boxes reflects the median of the
data set. The upper edge indicates the 75th percentile of the data set, whereas the lower edge indicates the 25th percentile.
The length of the box represents the inter quartile range (IQR). The whiskers mark the highest and lowest values within a
distance of 1.5 IQR to the box.
TABLE 2. Effect of preservation strategy and solution







Total morphology score P0.0001 P0.0001 No
Viability enterocytes P0.0031 P0.0017 No
Shape epithelium No P0.0001 No
Viability Stroma P0.0001 P0.023 No
Villi flattening No No No
Viability crypts P0.0018 P0.0007 No
Viability muscle layer No P0.023 No
RNA concentration P0.0003 P0.0001 No
ATP content P0.0003 No No
a P0.05 indicates superiority of slices of luminally preserved tissue
compared with slices of tissue that was not luminally exposed to the preser-
vation solution.
b P0.05 indicates superiority of slices of tissue preservedwithWMEplus
compared with slices of tissue that was preserved with UW.
c Interaction was found between preservation strategy and preservation
solution.
UW, University of Wisconsin; WMEplus, Williams Medium E with ad-
ditional buffering, impermeants, and a colloid.
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becomes manifest after reoxygenation (25). We were able to
reduce the encountered preservation and reoxygenation in-
jury by luminal preservation with an alternative solution
(WMEplus) for hypothermic preservation of the intestine af-
ter the standard vascular washout with UW solution. WME-
plus is based onWME (with L-glutamine), a relatively cheap,
ready-to-use medium, that contains many ingredients that
have previously shown to be beneficial for intestinal preser-
vation. To increase its potential as a preservation solution, we
added PEG (35 kDa), raffinose, lactobionate, and the power-
ful HEPES buffer. Because the composition of WMEplus dif-
fers inmany aspects fromUWsolution (Table 4), we can only
speculate about which ingredients are responsible for the ap-
parent superiority of WMEplus in this study. Earlier studies
have identified colloid agents, amino acids (AAs), and buff-
ering capacity as the possible crucial factors responsible for
the protective effect of luminal preservation with tailored
solutions (16, 22, 26).
WMEplus contains the colloid PEG instead of hydroxy-
ethyl starch inUW solution to reduce osmotic cell swelling. The
efficacy of hydroxyethyl starch is controversial (27, 28). Thewa-
ter-solublePEGmacromoleculewithabundanthydroxylgroups
is assumed to effectively retain water. Furthermore, PEG binds
to enterocyte-attached sphingolipids that may stabilize the epi-
thelium and prevent shifts of luminal contents (e.g., water
and electrolytes) into the tissue. In addition, PEG acts as a
free radical scavenger (29–31). Recently, Oltean et al. (32)
reported that intraluminal preservation with a PEG-con-
taining solution decreased preservation injury.
Fujimoto et al. showed improved viability of intestinal
grafts directly after preservation by using an AA-rich solution.
AAs are postulated to play a cytoprotective role by catering for
metabolic and synthetic elements of intestinal metabolism
(16, 22). This benefit wasmost pronounced after luminal expo-
sure toAAduringpreservation (16, 17, 33) andwas attributed to
a better maintenance of energy levels. Especially the most vul-
nerable epithelial cells at the villus top seem to benefit from
luminally supplied nutrients (17). WME (with L-glutamine)
contains 20 different AA. Particularly glutamine has been pro-
posed to be favorable for intestinal preservation, because it is the
main energy substrate of the enterocyte. The addition of glu-
tamine to the preservation solution requires high buffering ca-
pacity to counteract unphysiologic pH shifts when glutamine
metabolism is sustained in a system devoid of hepatic detoxi-
fication (16). For this reason, we have added the powerful
sulfonic buffer HEPES toWMEplus. Future studies should
FIGURE 2. Experimental set up. For all experimental groups, a vascular flush with 20 mL of ice-cold (4°C) of Wisconsin
(UW) solution was applied before preservation. The jejunum was retrieved and divided into five equal pieces, which were
randomly assigned to five different groups to exclude confounding by anatomical factors. Group 1: fresh control without
preservation. Group 2: UW closed preservation: The intestinal lumen was directly stapled with vascular clips (Titanium
Clips, Horizon, Teleflex Medical, NC) followed by cold, static storage (CS) in UW solution for 6 hr. Group 3: UW luminal
preservation: The intestinal lumen was flushed with 15 to 20 mL of UW solution. Then the distal lumen was closed, and the
intestine was filled (1–2 mL, hydrostatic pressure maximum 10 cm H2O). Finally, the proximal lumen was closed, followed
byCS inUWsolution for 6 hr.Group 4:WilliamsMediumEwith additional buffering, impermeants, and a colloid (WMEplus)
closedpreservation: the intestinal lumenwas directly stapledwith vascular clips followedbyCS inWMEplus for 6 hr.Group
5: WMEplus luminal preservation: the intestinal lumen was flushed with 15 to 20 mL of WMEplus. Then the distal lumen was
closed, and the intestine was filled. Finally, the proximal lumen was closed, followed by CS inWMEplus for 6 hr. T0 reflects
the timepoint at which preservation starts, whereas T6 reflects the end of the 6-hr preservation period. After reoxygenation,
T0–R6 reflects the time point at which slices from nonpreserved tissue have been reoxygenated for 6 hr, whereas T6–R6
reflects 6-hr reoxygenation of slices derived from tissue that was preserved for 6 hr.
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identify the beneficial effect of each ingredient, or group of
ingredients, of WMEplus by systematic comparison of a
range of solutions with different compositions.
Luminal preservation is postulated as an effective strategy
to reduce intestinal graft damage (11, 14, 16, 17, 32, 33). We
demonstrated that luminal preservation improved energy levels
ofpreserved tissuedirectly afterpreservationandafter reoxygen-
ation comparedwith closedpreservation. The luminal uptake of
additional cytoprotective agents such as AAmay not be the only
explanation for the increased viability because luminal preserva-
tion with UW solution also improved energy levels. Possibly,
both the dilution of enteric cytotoxic intestinal contents by lu-
minal flushing and the faster cooling during luminal preserva-
tion contributed to improvedgraft preservation, independent of
solution composition, as suggested before (14, 20). Luminal
preservation is clinically feasible by nasogastric administration
to the donor simultaneously with cold vascular perfusion.
The local production of proinflammatory cytokines, che-
mokines, and reactive oxygen species (ROS) during reoxygen-
ation of the ischemic tissue is a crucial early event in the cascade
that leads to tissue IRI (34, 35). These signaling factors trigger a
specific stress response aiming to counteract the physiologic
challenges provoked by reoxygenation. Precision-cut slices,
which contain all intestinal cell types (including residentmacro-
phages) in their physiologic matrix, have enabled us to mimic
this early phase of IRI, under ex vivowell-controlled conditions.
Several transcription factors are known to be activated
by reoxygenation-associated ROS formation. One of these
transcription factors is nuclear factor-E2-related factor 2
(Nrf2). Activation of Nrf2 has protective effects aiming to
counteract an ischemic insult by up-regulation of the expres-
sion of the antioxidant HO-1 (36), stress response protein
Hsp70 (37, 38), and tight junction proteins (39), which play a
central role inmaintaining the integrity of the intestinal phys-
ical barrier (6, 7), necessary to prevent (systemic) inflamma-
tion after ITx (3, 35, 40). We found that the gene expression
of Hsp70, HO-1, and tight junction proteins such as ZO-1,
claudin-3, and occludin-1 was generally up-regulated in
reoxygenated slices from preserved intestinal tissue. The
most marked up-regulation was consistently shown in
reoxygenated slices of tissue preserved with UW solution,
without luminal exposure. Because these slices also
showed most morphologic damage and had the lowest
ATP content, we concluded that most ischemic stress as a
result of ROS formation was induced in the latter preser-
vation group.
Another key factor in the origin of IRI is the nuclear
factor (NF)-B, which induces many proinflammatory re-
actions that serve as an adaptive mechanism on the one
hand but also reflect tissue damage on the other hand. A
number of studies have shown that suppression of NF-B
protects against IRI (41–44). Among the proteins that are
up-regulated because of induction by NF-B are the proin-
flammatory cytokine IL-6 (45) and iNOS, which both play a
role in IRI (3). We demonstrated that the expression of iNOS
and IL-6 is lower in tissue that is preserved with WMEplus
compared with UW solution. Furthermore, iNOS is signifi-
cantly less up-regulated after luminal preservation compared
with closed preservation. The lowest expression of bothNrf2-
and NF-B-driven stress responsive genes was consequently
demonstrated in tissue that was luminally preserved with
WMEplus, which also showed the bestmorphology and high-
TABLE 3. Gene expression in slices of preserved tissue










GAPDH 1.4 (0.7–3.2) 1.2 (0.7–3.2) 1.2 (0.9–1.3) 1.2 (0.8–1.8) No No No
Epithelial cell marker
Villin 0.4 (0.1–1.0) 0.5 (0.2–1.6) 0.4 (0.1–0.8) 0.9 (0.1–2.5) P0.007 No No
Proinflammatory marker
IL-6/GAPDH 4.6 (0.2–11.9) 3.1 (0.4–6.3) 2.3 (0.2–5.9) 1.5 (0.3–4.2) No P0.0082 No
Tight junction proteins
Occludin/villin 1.9 (0.9–5.3) 1.4 (0.9–2.7) 1.5 (0.8–2.5) 1.3 (0.8–2.5) No No No
ZO1/villin 3.8 (1.5–7.0) 2.9 (1.7–2.0) 2.5 (1.5–3.4) 2 (0.9–3.7) No P0.0065 No
Claudin-3/villin 2.5 (1.2–6.1) 2 (1.2–2.9) 1.7 (1.1–2.4) 1.4 (0.9–2.3) No P0.0059 No
Cellular stress marker
HSP-70/GAPDH 10.4 (1.2–51.8) 10.1 (1.5–50.5) 5.9 (1.5–22.3) 3.4 (0.7–8.6) No P0.04 No
HO-1/GAPDH 5.4 (1.8–8.0) 3.1 (2.0–6.4) 3.7 (1.7–8.5) 1.9 (0.8–4.7) P0.0006 P0.006 No
iNOS/villin 23.5 (0.8–66.2) 11 (0.3–63.4) 14.4 (0.3–69.0) 4.1 (0.2–14.2) P0.0014 P0.014 No
Values represent average fold expression (in bold) and range of the measured values. mRNA expression of control slices of not-preserved tissue incubated
for 6 hr is set to 1. , mRNA expression significantly up-regulated in comparison with control slices; , mRNA expression not significantly different from
control slices; , mRNA expression significantly down-regulated in comparison with control slices.
a Gene expression was significantly less affected in slices of luminally preserved tissue than in slices of tissue that was not luminally exposed to preservation
solution, P value is given.
b Gene expression was significantly less affected in slices of tissue preserved inWMEplus than in slices of tissue that was preserved with UW, P value is given.
c Interaction between preservation strategy and preservation solution.
UW, University of Wisconsin; WMEplus, Williams Medium E with additional buffering, impermeants, and a colloid; IL, interleukin; HSP-70, heat shock
protein 70; HO-1, heme oxygenase 1; iNOS, inducible nitric oxide synthase.
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est ATP content, indicating that the least stress was induced in
this group.
A limitation of this study is the lack of ultimate proof
using a transplant model. However, because the cascade of
injury after transplantation and in vivo reperfusion is rather
complex, we have deliberately chosen to first study the effect
of preservation in combination with reoxygenation in a mul-
ticellular reperfusionmodelwithout any alloreactive features.
In conclusion, our data consistently demonstrate that lumi-
nal preservation and preservation with WMEplus indepen-
dently reduce cellular stress and subsequent loss of viability of
preserved intestinal tissue after ex vivo reoxygenation. Our
next experiments will concern assessment of the proposed
strategy in a transplantmodel to further refine intestinal pres-
ervation and reduce intestinal graft injury, ultimately im-
proving the outcome after ITx.
MATERIALS ANDMETHODS
Animals
Adult male Wistar rats (n8, HsdCbp:Wu, 330–400 g, Harlan, Horst,
The Netherlands) were housed under standard conditions with free access to
drinkingwater and rat chow. The experimentswere conducted in accordance
with institutional and legislatory regulations.
Surgical Procedure
Rats were anesthetized under 5% isoflurane/O2, followed by 2.5% to
maintain anesthesia. A midline laparotomy was performed to expose the
aorta at the level of the celiac trunk. The supraceliac aorta was clamped, and
20mL of ice-cold (4°C)UW solution was administered retrogradely through
the infrarenal aorta through a 20-G canula. The suprahepatic vena cava was








Osmolarity (mOsm/L) 333 320
Viscosity at 5°C (cP) 5.7
Colloid/
impermeants
HES (250 kDa) (g/L) 50

















Total potassium 4.2 125
Total sodium 142 27


















































Components ofWMEarederived fromInvitrogen (http://products.invitrogen.
com/) andbold indicates extra additions toWME for this study.Components of
UW are derived from the instruction leaflet supplied with the solution.
UW, University of Wisconsin; WMEplus, Williams Medium E with ad-
ditional buffering, impermeants, and a colloid.
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transected to facilitate the outflow of blood and perfusate. Starting from 15
cm distally to the stomach, 30 cm of small intestine (jejunum) was excised.
Afterward, rats were killed.
Preservation Solutions
UW solution (Viaspan, Belzer, Du Pont, Bristol, United Kingdom) andWil-
liamsMedium Ewith additional buffering, impermeants, and a colloid (WME-
plus) were used as preservation solutions.WMEplus was prepared by adding 20
g/L polyethylene glycol (PEG; 35 kDa), 50 mmol/L raffinose, 30 mmol/L lacto-
bionate, and 10 mmol/L HEPES (Sigma-Aldrich, St Louis, MO) to Williams
Medium E (WME; with L-glutamine, Invitrogen, Paisley, United Kingdom).
Finally, four parts of the solution were diluted with one part of distilled water to
reach a final osmolarity of 330 mOsm/L. The pH was set to 7.4–7.5 by adding
NaOH (26mmol/L). Solution composition is specified in Table 4.
Experimental Groups
The excised jejunum of one rat was divided into five pieces of 5–6 cm,
which were randomly assigned to serve as fresh control without preservation
(group 1) or to be preserved according to one of the four different preserva-
tion protocols (groups 2–5) as illustrated in Figure 2. CS was performed on
melting ice for 6 hr in 5 mL of preservation solution.
Ex Vivo Reoxygenation
Precision-cut intestinal slices were prepared from control and preserved
intestinal segments as described previously (24, 46) and incubated at 37°C for
6 hr in 12-well culture plates in 1.3-mL Williams Medium E, supplemented
with L-glutamine, extra D-glucose (final concentration 25 mM), gentamicin
(50 g/mL, Invitrogen, Paisley, United Kingdom), and fungizone (2.5 g/
mL, Invitrogen, Paisley, United Kingdom) (24, 46), in an atmosphere of 95%
oxygen/5% CO2 (dissolved oxygen in the medium was 95% of maximal
saturation as measured by van Midwoud et al. [47]). For each outcome pa-
rameter, three slices were incubated, except for mRNA analysis by reverse-
transcriptase polymerase chain reaction for which six slices were used.
Outcome Parameters
The viability of fresh control tissue and preserved intestinal segments was
determined by the assessment of histomorphologic integrity and ATP level. In
reoxygenated slices, histomorphologic integrity, ATP levels, andmRNA expres-
sion of several stress-responsive genes (Tables 3 and 5) were determined.
Histologic Examination of Tissue
Full-thickness samples of control and preserved intestinal tissue were
fixed in 4% buffered formalin, dehydrated, embedded in paraffin, cut (3–5
m), and stained with hematoxylin-eosin. Histologic damage was assessed
using the Park Score (9).
Histologic Examination of Slices
Histomorphologic appearance of the slices after reoxygenation was assessed
using a scoring system that was developed to evaluate the integrity of cultured
intestinal slices. The structure of the slices was evaluated by ascribing a score
between 0 (no changes) and 3 to 6 aspects: viability and shape (columnar or flat)
of the epithelial cells, viability of the stroma, crypts, and muscle layer, and flat-
tening of the villi. Scores of the six separatemorphologic parameters were added
up to a total morphology score between 0 and 18, reflecting the overall integrity
of the slices. All histologic samples (tissue and slices) were evaluated by a pathol-
ogist blinded to the assignment of experimental groups.
ATPMeasurement in Tissue and Slices
ATP samples were immersed in 1-mL ice-cold 70% ethanol, containing 2
mM ethylenediaminetetraacetic acid (pH 10.9), directly snap-frozen in liq-
uid nitrogen, and stored at 80°C. The ATP content was determined after
centrifugation in the supernatant as described previously (24). The protein
content of tissue samples was determined in the pellet to normalize the ATP
concentration. ATP values of the slice were corrected with the average pro-
tein content of three slices from nonpreserved tissue. For this purpose, the
pellet was dissolved with 5 M NaOH and then diluted 50 times with MilliQ
water after which the protein content was determined colorimetrically using
BioRad protein assay dye reagent (Bio-Rad, Munich, Germany).
Gene Expression Levels
After reoxygenation, six slices were collected together in one sample vial,
snap-frozen in liquid nitrogen, and stored at80°C. After thawing, RNAwas
isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA was
prepared as described previously (5). Polymerase chain reaction was per-
formed according to the Table 5. All assays were performed at least in dupli-
cate. Dissociation curve analyses were performed for each reaction to check
the formation of one specific product. For each gene, the expression was
normalized with the mean computed tomographic threshold value of villin
(for genes expressed in epithelial cells) or GAPDH (other genes). Results
were expressed as 2[CT], which is an index of the amount of mRNA
expressed relative to the chosen house-keeping gene (GAPDH or villin) and
the expression in slices derived from nonpreserved tissue.
Statistics
Data were analyzed by fitting mixed-effect models (48). For the ATP con-
centration and the RNA expression calculations, values were first trans-
TABLE 5. Sequences of primers/genes of interest










The following amplification conditions were used for real time polymerase chain reaction.
a 10min at 95°C and then 40 cycles of amplification at 95°C for 15 sec, 56°C for 15 sec, and 72°C for 40 sec followed by a dissociation stage at 95°C for 15 sec,
60°C for 15 sec, and 95°C for 15 sec.
b 2 min at 50°C and 10 min at 95°C. This was followed by 40 cycles amplification consisting of denaturation for 15 sec at 95°C followed by annealing and
extension for 1 min at 60°C followed by a dissociation stage at 95°C for 15 sec, 60°C for 15 sec, and 95°C for 15 sec.
IL, interleukin; HSP-70, heat shock protein 70; HO-1, heme oxygenase 1; iNOS, inducible nitric oxide synthase.
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formed to the natural logarithm. The fitted models consisted of random
intercepts that were related to the individual rats (intestines) and the repli-
cates (of slices or pieces) measured for each outcome parameter within the
rat (intestine). The calculated fixed effects express the influence of the pres-
ervation solution or strategy on the outcome parameters. To be able to dis-
tinguish between the “solution effect” (UW solution vs. WMEplus) and the
“strategy effect” (closed vs. luminal preservation), a possible interaction be-
tween these parameterswas determined.Whenno interactionswere found, it
could be concluded that the solution effect was independent of the strategy
that was used and vice versa. Statistical package R (library NLME) was used
for computations. P values less than 0.05 were considered to be significant.
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